<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>
NEW YORK, Feb. 18, 2022 /PRNewswire/ — Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Biogen Inc. (NASDAQ: BIIB). To receive updates on the lawsuit, fill out the form: https://claimyourloss.com/securities/biogen-inc-loss-submission-form-2/?id=23818&from=4 The lawsuit seeks to recover losses for shareholders who purchased Biogen between June 7, 2021 and January 11, 2022.
...read full article on PRNewsWire
